NO173213C - Fremgangsmaate for fremstilling av et preparat omfattende et liposom - Google Patents

Fremgangsmaate for fremstilling av et preparat omfattende et liposom

Info

Publication number
NO173213C
NO173213C NO864960A NO864960A NO173213C NO 173213 C NO173213 C NO 173213C NO 864960 A NO864960 A NO 864960A NO 864960 A NO864960 A NO 864960A NO 173213 C NO173213 C NO 173213C
Authority
NO
Norway
Prior art keywords
liposom
preparing
procedure
preparation including
preparation
Prior art date
Application number
NO864960A
Other languages
English (en)
Other versions
NO864960L (no
NO173213B (no
Inventor
Andrew Stuart Janoff
Mircea Constantine Popescu
Alan Lee Weiner
Lois E Bolcsak
Paul A Tremblay
Christine E Swensson
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/721,630 external-priority patent/US4721612A/en
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NO864960L publication Critical patent/NO864960L/no
Publication of NO173213B publication Critical patent/NO173213B/no
Publication of NO173213C publication Critical patent/NO173213C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seal Device For Vehicle (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO864960A 1985-04-10 1986-12-09 Fremgangsmaate for fremstilling av et preparat omfattende et liposom NO173213C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/721,630 US4721612A (en) 1984-04-12 1985-04-10 Steroidal liposomes
US06/773,429 US4891208A (en) 1985-04-10 1985-09-10 Steroidal liposomes
PCT/US1985/001983 WO1986005977A1 (en) 1985-04-10 1985-10-10 Steroidal liposomes

Publications (3)

Publication Number Publication Date
NO864960L NO864960L (no) 1986-12-09
NO173213B NO173213B (no) 1993-08-09
NO173213C true NO173213C (no) 1993-11-17

Family

ID=27110456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864960A NO173213C (no) 1985-04-10 1986-12-09 Fremgangsmaate for fremstilling av et preparat omfattende et liposom

Country Status (16)

Country Link
US (1) US4891208A (no)
EP (1) EP0222771A4 (no)
JP (1) JPH0798741B2 (no)
KR (1) KR890001882B1 (no)
AU (2) AU596953B2 (no)
CA (1) CA1262334A (no)
DK (1) DK591086A (no)
ES (2) ES8700933A1 (no)
FI (1) FI92463C (no)
HU (1) HU203205B (no)
IE (1) IE66709B1 (no)
IL (1) IL76600A (no)
NO (1) NO173213C (no)
NZ (1) NZ213601A (no)
PT (1) PT81242B (no)
WO (1) WO1986005977A1 (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231112A (en) * 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
JPH0761940B2 (ja) * 1986-11-17 1995-07-05 株式会社資生堂 外皮用リポソ−ム製剤
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
NZ230424A (en) * 1988-08-25 1992-05-26 Liposome Co Inc Liposomal composition comprising an externally disposed antigen
AU627226B2 (en) * 1988-08-25 1992-08-20 Liposome Company, Inc., The Influenza vaccine and novel adjuvants
US5055303A (en) * 1989-01-31 1991-10-08 Kv Pharmaceutical Company Solid controlled release bioadherent emulsions
WO1992020323A1 (en) * 1991-05-16 1992-11-26 Vestar, Inc. Methods for the administration of drugs
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US5643600A (en) * 1991-09-17 1997-07-01 Micro-Pak, Inc. Lipid vesicles containing avocado oil unsaponifiables
DE4131878A1 (de) * 1991-09-25 1993-04-01 Henkel Kgaa Verfahren zur herstellung von liposomen
AU6365894A (en) * 1993-03-16 1994-10-11 Alliance Pharmaceutical Corporation Fluorocarbon compositions containing a visible or fluorescent label
CA2159596C (en) * 1993-04-02 2002-06-11 Royden Coe Method of producing liposomes
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5468224A (en) * 1993-11-30 1995-11-21 Souryal; Tarek O. Methods of color coding injectable medications
AU693488B2 (en) * 1993-12-15 1998-07-02 Novavax, Inc. Lipid vesicles containing avocado oil unsaponifiables
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
US5670163A (en) * 1994-06-20 1997-09-23 Kv Pharmaceuticals Company Long acting GI and esophageal protectant
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5554380A (en) * 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
EP0796112A4 (en) * 1994-11-30 1999-12-01 Amur Research Corp MEDICINAL DERIVATIVES OF PHOSPHOCHOLIN
US5759519A (en) * 1995-06-07 1998-06-02 Gen-Probe Incorporated Method for the intracellular delivery of biomolecules using thiocationic lipids
US5711964A (en) * 1995-06-07 1998-01-27 United States Of America Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D
US5739271A (en) * 1995-06-07 1998-04-14 Gen-Probe Incorporated Thiocationic lipids
US5756352A (en) * 1995-06-07 1998-05-26 Gen-Probe Incorporated Thiocationic lipid-nucleic acid conjugates
US5851548A (en) * 1995-06-07 1998-12-22 Gen-Probe Incorporated Liposomes containing cationic lipids and vitamin D
US5763423A (en) * 1996-01-04 1998-06-09 Clarion Pharmaeuticals Inc. Pharmaceutical compositions, novel uses, and novel form of tocopherylphosphocholine
EP0948341A4 (en) * 1996-09-17 2003-05-21 Supergen Inc DERIVATIVES OF PHOSPHOLIPIDIC DRUGS
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
US7169410B1 (en) * 1998-05-19 2007-01-30 Sdg, Inc. Targeted liposomal drug delivery system
PL364087A1 (en) * 2001-02-21 2004-12-13 Basf Aktiengesellschaft Method for the production of d-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
US7858117B2 (en) * 2002-02-21 2010-12-28 Novosom Ag Amphoteric liposomes and their use
HU226519B1 (en) * 2002-11-26 2009-03-30 Istvan Dr Horvath Artificial blood made of hemoglobin encapsulated in membrane
WO2005063212A1 (en) * 2003-12-31 2005-07-14 Amorepacific Corporation Cholesteryl hemisuccinate incorporated lipid-based nano-carriers and skin-care compositions for external application containing the same
EP1722762A2 (en) * 2004-03-02 2006-11-22 Massachusetts Institute of Technology Nanocell drug delivery system
US20070053845A1 (en) * 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
US20070065359A1 (en) * 2005-03-14 2007-03-22 Shiladitya Sengupta Nanocells for diagnosis and treatment of diseases and disorders
KR101172066B1 (ko) 2005-09-30 2012-08-10 (주)아모레퍼시픽 스티그마스테릴 헤미숙시네이트를 포함한 지질-기반 약물전달체 및 이를 함유하는 피부 외용제 조성물
US20100068264A1 (en) * 2006-07-12 2010-03-18 University Of South Florida Niosome-hydrogel drug delivery system
US20080317768A1 (en) 2007-06-21 2008-12-25 Boeing Company Bioconjugated nanoparticles
US10688026B2 (en) 2009-04-27 2020-06-23 Premier Dental Products Company Buffered microencapsulated compositions and methods
US9814657B2 (en) 2009-04-27 2017-11-14 Premier Dental Products Company Buffered microencapsulated compositions and methods
WO2015084677A1 (en) * 2013-12-02 2015-06-11 Arytha Biosciences, Llc Toxoid preparation and uses thereof
US9522114B1 (en) 2014-03-27 2016-12-20 University Of South Florida Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1142147A (en) * 1965-05-28 1969-02-05 Glaxo Lab Ltd A process for making free-flowing gel particles
US3932657A (en) * 1973-11-12 1976-01-13 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome encapsulation of chelating agents
DE2404047A1 (de) * 1974-01-29 1975-08-14 Henkel & Cie Gmbh Hautpflege- und hautschutzmittel mit einem gehalt an haut-feuchthaltemitteln
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
US4040784A (en) * 1976-08-23 1977-08-09 Deshmukh Arvind D Method for checking the accuracy of a test, using a serum-soluble cholesterol compound
US4183847A (en) * 1976-08-23 1980-01-15 Deshmukh Arvind D Enzymatically hydrolyzable, serum-soluble cholesterol compounds and method for their preparation
US4042330A (en) * 1976-08-23 1977-08-16 Deshmukh Arvind D In a method for checking the accuracy of a test using an enzymatically hydrolyzable, serum-soluble cholesterol compound
DE2860862D1 (en) * 1977-10-13 1981-10-29 Siegfried Ag Imidazolylethylene-oxyalkyloxy derivatives and their thio analogues, methods for their preparation and pharmaceutical compositions containing them
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4298594A (en) * 1978-04-14 1981-11-03 Arthur D. Little, Inc. Xenobiotic delivery vehicles, method of forming them and method of using them
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
GR73668B (no) * 1978-11-21 1984-03-28 Hoffmann La Roche
US4342739A (en) * 1979-01-09 1982-08-03 Fuji Photo Film Co., Ltd. Novel material for immunological assay of biochemical components and a process for the determination of said components
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
EP0032578B1 (de) * 1980-01-16 1984-07-25 Hans Georg Prof. Dr. Weder Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4617161A (en) * 1983-09-06 1986-10-14 Baxter Travenol Laboratories, Inc. Method of manufacture for a dialyzer having improved side ports
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes

Also Published As

Publication number Publication date
IL76600A0 (en) 1986-02-28
AU4434589A (en) 1990-05-17
JPH0798741B2 (ja) 1995-10-25
EP0222771A1 (en) 1987-05-27
FI92463C (fi) 1994-11-25
US4891208A (en) 1990-01-02
FI92463B (fi) 1994-08-15
HU203205B (en) 1991-06-28
FI865021A0 (fi) 1986-12-10
WO1986005977A1 (en) 1986-10-23
IE852336L (en) 1986-10-10
IL76600A (en) 1992-12-01
EP0222771A4 (en) 1988-06-08
ES547326A0 (es) 1986-11-16
NZ213601A (en) 1990-03-27
HUT42322A (en) 1987-07-28
CA1262334C (en) 1989-10-17
KR870700347A (ko) 1987-12-28
DK591086D0 (da) 1986-12-09
FI865021A (fi) 1986-12-10
CA1262334A (en) 1989-10-17
PT81242B (pt) 1987-10-20
ES553808A0 (es) 1988-01-01
AU4952885A (en) 1986-11-05
DK591086A (da) 1986-12-09
ES8801085A1 (es) 1988-01-01
ES8700933A1 (es) 1986-11-16
JPS62502464A (ja) 1987-09-24
KR890001882B1 (ko) 1989-05-29
AU609647B2 (en) 1991-05-02
PT81242A (en) 1985-11-01
IE66709B1 (en) 1996-01-24
NO864960L (no) 1986-12-09
AU596953B2 (en) 1990-05-24
NO173213B (no) 1993-08-09

Similar Documents

Publication Publication Date Title
NO173213C (no) Fremgangsmaate for fremstilling av et preparat omfattende et liposom
NO882103D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO170516C (no) Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat
NO171826C (no) Fremgangsmaate for fremstilling av et stabilt nicorandilholdig preparat
NO171948C (no) Oralt preparat
NO880520L (no) Fremgangsmaate for fremstilling av et cholestyraminpreparat
NO174572C (no) Oralt preparat
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
NO167034C (no) Fremgangsmaate for fremstilling av 1,6-diklor-1,6-dideoksy-beta-d-fruktofuranosyl-4-kloro-4-dioksy-alfa-galactopyranosid
NO171781C (no) Fremgangsmaate for fremstilling av en selvbaerende keramiskstruktur
NO812827L (no) Fremgangsmaate for fremstilling av et bacampicillinpreparat
NO934897L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO170079C (no) Fremgangsmaate for fremstilling av et krystallinsk torasemid
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
NO864269L (no) Fremgangsmaate for fremstilling av en naeringsmiddelemulsjon
NO870368D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med langvarig virkning.
NO901232D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO171910C (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler
NO169601C (no) Fremgangsmaate for fremstilling av trippelklonet hepatitt a vaksine
FI93172C (fi) Menetelmä hajunpoistoaineen valmistamiseksi
NO173727C (no) Fremgangsmaate for fremstilling av et preparat mot psoriasis
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
FI92396B (fi) Uusi menetelmä valmistaa metyleenidioksifenantreeniyhdisteitä
NO874539D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO172095C (no) Framgangsmaate for framstilling av sondenaering

Legal Events

Date Code Title Description
MK1K Patent expired